Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
11/2001
11/15/2001WO2001085967A2 Corynebacterium glutamicum strain with enhanced secretion activity
11/15/2001WO2001085956A2 Lipid metabolism enzymes
11/15/2001WO2001085955A1 Rh116 polypeptides and its fragments and polynucleotides encoding said polypeptides and therapeutic uses
11/15/2001WO2001085954A2 Serine-threonine kinase-3
11/15/2001WO2001085953A1 Sphingosine kinase and uses thereof
11/15/2001WO2001085952A2 Modified inosine 5'-monophosphate dehydrogenase polypeptides and uses thereof
11/15/2001WO2001085950A2 Genes of the 1-desoxy-d-xylulose biosynthesis path
11/15/2001WO2001085946A2 Nucleic acid molecules encoding plant cell cycle proteins and uses therefor
11/15/2001WO2001085942A2 Cytoskeleton-associated proteins
11/15/2001WO2001085941A2 Myc targets
11/15/2001WO2001085938A1 Modified es cells and es cell-specific gene
11/15/2001WO2001085937A2 Regulator of g protein signalling (rgs8)
11/15/2001WO2001085936A1 F-box containing protein
11/15/2001WO2001085935A2 Endothelial differentiation gene 6-like g protein coupled receptor
11/15/2001WO2001085934A1 New ras guanine-nucleotide-exchange factor 1 (nrg1)
11/15/2001WO2001085926A2 Nucleotide sequences involved in increasing or decreasing mammalian ovulation rate
11/15/2001WO2001085924A2 MODULATION OF η-SECRETASE ACTIVITY
11/15/2001WO2001085921A2 Human serine-threonine kinase-4
11/15/2001WO2001085915A2 Identifying clusters of transcription factor binding sites
11/15/2001WO2001085913A2 High purity x-chromosome bearing and y-chromosome bearing populations of spermatozoa
11/15/2001WO2001085912A2 Presenilin enhancers
11/15/2001WO2001085911A2 Chromosome 17p-linked prostate cancer susceptibility gene and a paralog and orthologous genes
11/15/2001WO2001085910A2 Agents that modulate dna-pk activity and methods of use thereof
11/15/2001WO2001085905A2 Isolated gum operon from xyllela fastidiosa, isolated nucleic acid molecules therefrom, and uses thereof
11/15/2001WO2001085797A1 Human igm antibodies with the capability of inducing remyelination, and diagnostic and therapeutic uses thereof particularly in the central nervous system
11/15/2001WO2001085785A2 Ph domain-interacting protein
11/15/2001WO2001085784A2 POLYNUCLEOTIDES ENCODING FOR POLYMORPHIC ISOFORMS OF THE PTHrP PROTEIN, THE ENCODED PROTEINS AND THEIR THERAPEUTIC APPLICATIONS THEREOF
11/15/2001WO2001085779A2 Protein complexes and assays for screening anti-cancer agents
11/15/2001WO2001085772A2 Virulence genes, proteins, and their use
11/15/2001WO2001085771A1 Novel ttv-related virus s-ttv
11/15/2001WO2001085770A2 Sentinel virus ii
11/15/2001WO2001085766A2 Novel eosinophil cationic proteins used in the treatment of asthmatic and allergic disorders
11/15/2001WO2001085762A2 Cancer diagnosis and assays for screening anti-cancer agents
11/15/2001WO2001085742A2 Haplotypes of the npy1r gene
11/15/2001WO2001085741A2 Haplotypes of the sod1 gene
11/15/2001WO2001085664A2 Compounds and methods for regulating bacterial growth and pathogenesis
11/15/2001WO2001085341A1 Microfluidic devices
11/15/2001WO2001085340A2 Method for the identification, quantification, and visualisation of micro-organisms
11/15/2001WO2001085334A2 Chemical structure identification
11/15/2001WO2001085219A2 Identification, diagnosis, and treatment of breast cancer
11/15/2001WO2001085215A2 METHODS OF MODULATING FUNCTIONS OF POLYPEPTIDE GalNAc TRANSFERASES AND OF SCREENING SUBSTANCES THEREFOR, PHARMACEUTICAL COMPOSITIONS COMPRISING SUCH AGENTS
11/15/2001WO2001085187A1 Use of hydrogenotrophic acetogenic strains for preventing or treating digestive disorders
11/15/2001WO2001085157A1 Compositions and methods for treatment of proliferative disorders
11/15/2001WO2001085096A2 Mast cell regulation
11/15/2001WO2001084903A2 Method for detecting and identifying the presence of biological substances derived from birds, and oligonucleotides therefor
11/15/2001WO2001049879A3 Methods for comparing gene expression levels or patterns in normal or tumor cells
11/15/2001WO2001044495A3 Diethoxyfluorescein as indicator for cytochrome p450
11/15/2001WO2001042794A3 Method for identifying inhibitors of cytokinesis
11/15/2001WO2001042487A3 Device for extraction of nucleic acids
11/15/2001WO2001038565A3 Oligomer array with pna and/or dna oligomers on a surface
11/15/2001WO2001034773A8 METHODS AND COMPOSITIONS FOR DIAGNOSING AND TREATING CHROMOSOME 18q RELATED DISORDERS
11/15/2001WO2001032882A3 Nucleic acids and proteins from group b streptococcus
11/15/2001WO2001021835A3 Method to determine the susceptibility of scrapie in sheep
11/15/2001WO2001020023A3 Method for the detection of oxidized forms of soluble guanylate cyclase
11/15/2001WO2001018244A3 Selection system
11/15/2001WO2001016292A8 37 staphylococcus aureus genes and polypeptides
11/15/2001WO2001016150A3 Nucleoside analogues
11/15/2001WO2001011361A3 Kit and method to assess the malignancy of neoplasias
11/15/2001WO2001007088A3 Methods for treating therapy-resistant tumors
11/15/2001WO2001004344A3 Induction of a th1-like response in vitro
11/15/2001WO2001002550A3 Cell death related drug targets in yeast and fungi
11/15/2001WO2001000880A3 Diagnostics and therapeutics for diseases associated with an il-1 inflammatory haplotype
11/15/2001WO2000067737A3 USE OF HMGCoA REDUCTASE INHIBITORS IN THE PREVENTION OF DISEASES WHOSE PATHOGENESIS IS DEPENDENT ON NEOVASCULARIZATION
11/15/2001WO2000063379A3 The p2x3 receptor, methods of altering p2x3 receptor activity and uses thereof
11/15/2001WO2000061780A9 Compositions and methods for extending life span
11/15/2001WO2000055323A9 Differential expression of organellar gene products
11/15/2001WO2000053232A9 Matriptase, a serine protease and its applications
11/15/2001WO2000050872A9 A system for cell-based screening
11/15/2001WO2000046369A3 Polynucleotides related to pancreatic disease
11/15/2001WO2000026370A9 Adenine nucleotide translocator (ant) fusion proteins and uses thereof
11/15/2001US20010041965 Polymorphism detection utilizing clustering analysis
11/15/2001US20010041964 Pharmacokinetic-based drug design tool and method
11/15/2001US20010041668 Selecting compound that is functionally equivalent to a gene product expressed in an embryo's extraembryonic tissue, causing the compound to access the cells to stimulate cells to undergo hematopoiesis and vascular growth
11/15/2001US20010041566 Bitwise monitoring of network performance
11/15/2001US20010041357 Polymerase chain reaction
11/15/2001US20010041352 Method and kit for detecting microorganisms
11/15/2001US20010041351 Transition metal oxide
11/15/2001US20010041342 Using apoptosis inhibiting protein
11/15/2001US20010041340 Genetic engineering
11/15/2001US20010041339 Bundling fibers; gluing to backing
11/15/2001US20010041335 Methods and compositions for amplifying detectable signals in specific binding assays
11/15/2001US20010041334 Genetic engineering
11/15/2001US20010041333 High throughput screening for a bioactivity or biomolecule
11/15/2001US20010041332 Isolation nucleic acids by binding to solid phase
11/15/2001US20010041331 Methods of utilizing the TT virus
11/15/2001US20010041178 Preventing airway mucus production by administration of EGF-R antagonists
11/15/2001DE10065632A1 Detecting polynucleotides by hybridizing an array of sequences on a carrier with detection probes, but not immobilized
11/15/2001DE10023422A1 Separation and detection of substances such as bio-polymers with fluorescent markers, comprises using parallel microcapillaries filled with gel matrix
11/15/2001DE10022362A1 Verfahren zum Auffinden von Modulatoren von Enzymen des Carotenoid-Biosyntheseweges A method for finding modulators of enzymes of the carotenoid biosynthesis pathway
11/15/2001DE10021834A1 New mRNA indicative of T cell activation and functional status, useful for diagnosis and therapy e.g. of autoimmunity or transplant rejection
11/15/2001DE10021688A1 New DNA sequences involved in isoprenoid biosynthesis, useful in screening for compounds with e.g. antimicrobial and herbicidal activity
11/15/2001DE10019119A1 New leukotriene Bx receptor gene, LTBx, useful for diagnosis and treatment of LTBx-related diseases
11/15/2001CA2804977A1 Compositions and methods for demonstrating secretory immune system regulation of steroid hormone responsive cancer cell growth
11/15/2001CA2803844A1 Compositions and methods for demonstrating secretory immune system regulation of steroid hormone responsive cancer cell growth
11/15/2001CA2803774A1 A particle differentiation apparatus for spermatozoa
11/15/2001CA2768046A1 Nucleic acid molecules encoding plant cell cycle proteins and uses therefor
11/15/2001CA2535867A1 Mixed cell diagnostic systems
11/15/2001CA2409515A1 Human igm antibodies with the capability of inducing remyelination, and diagnostic and therapeutic uses thereof particularly in the central nervous system
11/15/2001CA2409512A1 Improvements to the fluorescent polymer-qtl approach to biosensing
11/15/2001CA2409510A1 Method for detecting growth hormone variations in humans, the variations and their uses
1 ... 2379 2380 2381 2382 2383 2384 2385 2386 2387 2388 2389 2390 2391 2392 2393 2394 2395 2396 2397 2398 2399 ... 3003